Low rate of COVID-19 vaccination in Africa: a cause for concern-Reference-Cited by-同舟云学术

Low rate of COVID-19 vaccination in Africa: a cause for concern

Published:2022-01 Issue: Volume:10 Page:251513552210881
ISSN:2515-1355
Container-title:Therapeutic Advances in Vaccines and Immunotherapy
language:en
Short-container-title:Therapeutic Advances in Vaccines and Immunotherapy

Author:

Al-Kassim Hassan Mohammed¹^ORCID,Adam Bala Auwal²,Jatau Abubakar Ibrahim³

Affiliation:

1. Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria

2. Department Pharmacology, College of Medicine and Health Sciences, Federal University Dutse, Nigeria

3. School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS, Australia

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/25151355221088159

Reference15 articles.

1. Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

2. The future of COVID-19: A vaccine review

3. Director-General’s opening remarks at the World Health Assembly – 24 May 2021, https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-world-health-assembly-24-may-2021 (accessed 16 September 2021).

4. More than 9.52 billion shots given: covid-19 vaccine tracker, https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/ (accessed 12 January 2022).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the potential public health impact of different vaccination strategies with an adapted vaccine in South Africa;Expert Review of Vaccines;2024-08-28

2. Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin;Frontiers in Immunology;2023-08-09

3. COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated;Vaccines;2023-05-22

4. Assessing the Impact of Vaccination on the Dynamics of COVID-19 in Africa: A Mathematical Modeling Study;Vaccines;2023-04-17

5. Why patent waiver for Covid‐19 vaccines and pharmaceuticals?;The Journal of World Intellectual Property;2023-04-06